Versantis initiated the first clinical trial of its lead candidate VS-01 for cirrhotic patients with hepatic encephalopathy.
Two new patents accepted in Mexico and South Korea! Versantis can now count on 6th granted patent securing the science & technology behind its lead candidate.
Einblick magazine features Versantis as a life-saving innovative company!
V Forster about entrepreneurial motivations in Tages Anzeiger
For the 3rd year in a raw, Versantis is in the Top100 best Swiss startups and was the #1 BEST BIOTECH STARTUP!
Versantis wins MassChallenge Switzerland!!
HOMEABOUT USDISEASE AREASPRODUCTSNEWSCAREERS
Versantis AGTechnoparkstrasse 13rd floor, Newton wing 3007CH-8005 ZurichSwitzerland
Copyright © 2019Versantis AG